Log In
Print
BCIQ
Print
Print this Print this
 

Epidiolex

  Manage Alerts
Collapse Summary General Information
Company GW Pharmaceuticals plc
DescriptionOral liquid formulation of cannabidiol (CBD), a phytocannabinoid found in Cannabis sativa
Molecular Target Cannabinoid receptors
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentIND
Standard IndicationEpilepsy
Indication DetailsTreat children with Dravet syndrome; Treat Lennox-Gastaut syndrome (LGS); Treat treatment-resistant epilepsy
Regulatory Designation

U.S. - Fast Track (Treat children with Dravet syndrome);
U.S. - Orphan Drug (Treat children with Dravet syndrome);
U.S. - Orphan Drug (Treat Lennox-Gastaut syndrome (LGS))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today